Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3663)

[301]

Jelen, M.M.; Chen, Z.; Kocjan, B.J.; Hošnjak, L.; Burt, F.J.; Chan, P.K.; Chouhy, D.; Combrinck, C.E.; Estrade, C.; Fiander, A.; Garland, S.M.; Giri, A.A.; González, J.V.; Gröning, A.; Hibbitts, S.; Luk, T.N.; Marinic, K.; Matsukura, T.; Neumann, A.; Oštrbenk, A.; Picconi, M.A.; Sagadin, M.; Sahli, R.; Seedat, R.Y.; Seme, K.; Severini, A.; Sinchi, J.L.; Šmahelová, J.; Tabrizi, S.N.; Tachezy, R.; Tohme Faybush, S.; Uloza, V.; Uloziene, I.; Wong, Y.W.; Židovec Lepej, S.; Burk, R.D.; Poljak, M.

Global genomic diversity of human papillomavirus type 11 (HPV11) based on 433 isolates and 78 complete genome sequences

[year of publication 2016, impact factor 4.663 ]

[302]

Anbazhagan, R.; Bartkova, J.; Stamp, G.; Pignatelli, M.; Gusterson, B.; Bartek, J.

Expression of integrin subunits in the human infant breast correlates with morphogenesis and differentiation

[year of publication 2006, impact factor 4.617]

[303]

Sijmons, S.; Thys, K.; Mbong Ngwese, M.; Van Damme, E.; Dvorak, J.; Van Loock, M.; Li, G.; Tachezy, R.; Busson, L.; Aerssens, J.; Van Ranst, M.; Maes, P.

High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination

[year of publication 2015, impact factor 4.606 ]

[304]

Huang, M.L.-H.; Austin, C.J.D.; Sari, M.-A.; Rahmanto, Y.S.; Ponka, P.; Vyoral, D.; Richardson, D.R.

Hepcidin bound to alpha(2)-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels

[year of publication 2013, impact factor 4.600 ]

[305]

de Witte, T.; Brand, R.; van Biezen, A.; Mufti, G.; Ruutu, T.; Finke, J.; von dem Borne, P.; Vitek, A.; Delforge, M.; Alessandrino, P.; Harlahakis, N.; Russell, N.; Martino, R.; Verdonck, L.; Kröger, N.; Niederwieser, D.

Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors : delay of the transplant is associated with inferior survival.

[year of publication 2010, impact factor 4.597]

[306]

Hubacek, P.; Virgili, A.; Ward, K.N.; Pohlreich, D.; Keslova, P.; Goldova, B.; Markova, M.; Zajac, M.; Cinek, O.; Nacheva, E.P.; Sedlacek, P.; Cetkovsky, P.

HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis

[year of publication 2009, impact factor 4.597]

[307]

Rodriguez-Emmenegger, C.; Brynda, E.; Riedel, T.; Houska, M.; Šubr, V.; Alles, A.B.; Hasan, E.; Gautrot, J.E.; Huck, W.T.S.

Polymer brushes showing non-fouling in blood plasma challenge the currently accepted design of protein resistant surfaces

[year of publication 2011, impact factor 4.596 ]

[308]

Petrak, J.; Ivanek, R.; Toman, O.; Cmejla, R.; Cmejlova, J.; Vyoral, D.; Zivny, J.; Vulpe, C.D.

Déja vu in proteomics : a hit parade of repeatedly identified differentially expressed proteins.

[year of publication 2008, impact factor 4.586]

[309]

Sutak, R.; Xu, X.; Whitnall, M.; Abul, K.; Pucci, H.; Koenig, M.; Vyoral, D.; Richardson, D.R.

Proteomic analysis of hearts from frataxin knockout mice : marked rearrangement of energy metabolism, a response to cellular stress and altered expression of proteins involved in cell structure, motility and metabolism

[year of publication 2008, impact factor 4.586]

[310]

Jiroušková, M.; Dyr, J.E.; Suttnar, J.; Holada, K.; Trnková, B.

Platelet adhesion to fibrinogen, fibrin monomer, and fibrin protofibrils in flowing blood : the effect of fibrinogen immobilization and fibrin formation

[year of publication 2006, impact factor 4.582]

[311]

Majek, P.; Pecankova, K.; Maly, M.; Oravec, M.; Riedel, T.; Dyr, J.E.

N-glycosylation of apolipoprotein A1 in cardiovascular diseases

[year of publication 2014, impact factor 4.557 ]

[312]

Brodská, B.; Otevřelová, P.; Šálek, C.; Fuchs, O.; Gašová, Z.; Kuželová, K.

High PD-L1 expression predicts for worse outcome of leukemia patients with concomitant NPM1 and FLT3 mutations

[year of publication 2019, impact factor 4.556 ]

[313]

Schäfer, V.; White, H.E.; Gerrard, G.; Möbius, S.; Saussele, S.; Franke, G.-N.; Mahon, F.-X.; Talmaci, R.; Colomer, D.; Soverini,S.; Machova Polakova, K.; et al.

Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network

[year of publication 2021, impact factor 4.553 ]

[314]

Hruba, P.; Krejcik, Z.; Stranecky, V.; et al.

Molecular patterns discriminate accommodation and subclinical antibody-mediated rejection in kidney transplantation

[year of publication 2019, impact factor 4.546 ]

[315]

Bartkova, J.; Lukas, J.; Strauss, M.; Bartek, J.

Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein

[year of publication 2006, impact factor 4.518]

[316]

Robin, M.; Porcher, R.; Zinke-Cerwenka, W.; van Biezen, A.; Volin, L.; Mufti, G.; Craddock, C.; Finke, J.; Richard, C.; Passweg, J.; Peniket, A.; Maertens, J.; Sucak, G.; Gedde-Dahl, T.; Vitek, A.; Nagler, A.; Blaise, D.; Beelen, D.; Maillard, N.; Schwerdtfeger, R.; de Witte, T.; Kroger, N.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: A retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

[year of publication 2017, impact factor 4.497 ]

[317]

Schetelig, J.; de Wreede, L.C.; van Gelder, M.; Andersen, N.S.; Moreno, C.; Vitek, A.; et al.

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

[year of publication 2017, impact factor 4.497 ]

[318]

van Gelder, M.; de Wreede, L.C.; Bornhäuser, M.; Niederwieser, D.; Karas, M.; Anderson, N.S.; Gramatzki, M.; Dreger, P.; Michallet, M.; Petersen, E.; Bunjes, D.; Potter, M.; Beelen, D.; Cornelissen, J.J.; Yakoub-Agha, I.; Russell, N.H.; Finke, J.; Schoemans, H.; Vitek, A.; et al.

Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

[year of publication 2017, impact factor 4.497 ]

[319]

Mareček, F.; Dyr, J.E.; Cajthamlová, H.; Medvěd, L.; Gorkun, O.; Suttnar, J.

Immunodominant conformational epitopes on the d-domain of human and bovine fibrinogens

[year of publication 2006, impact factor 4.481]

[320]

Dyr, J.E.; Cajthamlová, H.; Fořtová, H.; Suttnar, J.

The effect of adhesion on the proteolysis of human fibrinogen

[year of publication 2006, impact factor 4.481]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 305

Deputy head of Science and Research Division
Tel:+420 221 977 648

Secretary
Tel:+420 221 977 144


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here